HOME >> MEDICINE >> NEWS
Vanderbilt University Medical Center designated as one of three Glaxo Wellcome Genetic Epidemiology Centers

Vanderbilt's Program in Human Genetics will play a central role in efforts by Glaxo Wellcome to identify the genes involved in common diseases. The pharmaceutical giant has designated Vanderbilt as one of the initial three Genetic Epidemiology Centers in the world.

The designation is part of a large-scale plan by Glaxo Wellcome to harness the power of genetics for drug development and discovery.

"Knowing the genes involved in a specific disease will mean that new pharmaceuticals can be targeted to the patients most likely to benefit," said Jonathan L. Haines, Ph.D., associate professor of Molecular Physiology and Biophysics and director of the Program in Human Genetics. "Using the genes as probes to understand the biology of the disease will lead to the discovery of better drug targets and the development of more effective drugs."

Haines helped Glaxo Wellcome develop its plan for setting up Clinical Genetics Networks to search for the genetic basis of common diseases.

"I have known and collaborated with Jonathan Haines for two decades and asked him to be a consultant when we set up the Genetics Directorate," said Dr. Allen D. Roses, vice president and world-wide director for Genetics at Glaxo Wellcome. "Jonathan is a talented and experienced genetic epidemiologist and has insight into the analysis of susceptibility gene research."

The Glaxo Wellcome plan includes:

  • Clinical networks to identify candidate families and collect clinical information and blood samples;

  • DNA Banking and Genotyping Centers to isolate DNA, store blood and DNA samples, and conduct high throughput genotyping; and

  • Genetic Epidemiology Centers to design and coordinate an entire project and analyze the results.

In addition to Vanderbilt, Duke and Boston University Medical Centers will serve as Genetic Epidemiology Centers.

"Glaxo Wellcome ultimately expects to study several diseases of major unmet medical need," Haines said. "At Vanderb
'"/>

Contact: Matt Scanlan or John Howser
matt.scanlan@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
22-Jul-1999


Page: 1 2

Related medicine news :

1. Childrens Hospital at Vanderbilt ranked 8th in nation by Child magazine
2. Diabetic eye screening bill based on Vanderbilt model
3. New endowed chair established at Vanderbilt to promote brain resesarch
4. Fran Visco receives Frances Williams Preston Award from Vanderbilt University
5. Special Fulbright awarded to Vanderbilt ethnomusicologist
6. Meharry-Vanderbilt partnership aims to address racial disparity in cancer outcomes
7. Vanderbilt School of Nursing begins graduate program in correctional health
8. Vanderbilt Cancer Center Discovery May Help Overcome Resistance To Anti-Breast Cancer Drug
9. Indiana University researchers closer to helping hearing-impaired using stem cells
10. Boston University team finds link between high cholesterol and better cognitive performance
11. University seeks recruits for arthritis study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/4/2020)... ... July 03, 2020 , ... The latest ... latest content hub— Future Lab: COVID-19 R&D . , Future Lab ... and products within specific scientific niches. Since their launch four years ago, the ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... the treatment of autoimmune diseases. Its lead indication is vitiligo. Vitiligo patients ... this time. , While vitiligo is equally prevalent in all ethnic ...
(Date:7/2/2020)... ... ... Allegheny Health Network (AHN) today announced that John S. Lee, MD, has ... Dr. Lee succeeds Robert White, MD, who announced his plans for retirement earlier this ... help support a seamless transition. , Dr. Lee joins AHN from Edward-Elmhurst Healthcare, based ...
(Date:7/1/2020)... ... 01, 2020 , ... ABSTRAX, an industry leader in the ... new terpene infused product line including custom rolling papers, cones, flat wraps, and ... and flavors worldwide. , “We’ve made it easier than ever for brands to ...
(Date:7/1/2020)... ... July 01, 2020 , ... G-CON ... been selected by Codiak BioSciences to support its cleanroom build out at its ... infrastructure for the drug substance and product manufacturing for its clinical pipeline. , ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... ... 01, 2020 , ... Lumeda Inc. (“Lumeda”), a ... formation of its Scientific Advisory Board with the appointment of a panel of ... to support company development and introduction of its PDT products to the clinic. ...
(Date:6/25/2020)... ... 25, 2020 , ... R3 Medical Training announced today it is now enrolling ... locations. The first course is August 6-7, 2020 in San Diego and the second ... a Virtual Live Stream option. , The two day agenda for each course is ...
(Date:6/25/2020)... ... 2020 , ... The FSHD Society announced the opening today ... conducted entirely online for the first time in the organization’s history. The conference ... of state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). A record 210 researchers, clinicians, ...
Breaking Medicine Technology:
Cached News: